UPC Analytics
ENDE
Overview · Filed: Aug 30, 2024

UPC_CFI_463/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Parent infringement case:UPC_CFI_145/2024

RevocationCounter Claim for RevocationMunich LDCounter claim for revocationCase Closed
OverviewDecisionsDocumentsTimeline
Parties

Claimants

  • Accord Healthcare S.L.U.
  • Accord Healthcare B.V.
  • Accord Healthcare GmbH
  • Accord Healthcare Italia Srl
  • Accord Healthcare, Unipessoal Lda.
  • Accord Healthcare AB

Respondents

Judges
  • Matthias Zigann
  • Alima Zana
  • Tobias Pichlmaier
Patents
  • EP2493466
CPC codes: A61K38/193, A61K31/573, A61P35/04, A61K31/164, A61K31/56, A61P43/00, A61P13/08, A61P15/00, A61K31/337, A61P35/00, A61K45/06, A61P25/16

Technology area: Pharmaceuticals · Small Molecule

Sector: Pharmaceutical & Medical

Outcome
—
Filed: Aug 30, 2024
First decided: —
Language: English
Open on UPC Registry